The MarketWatch News Department was not involved in the creation of this content. ATHERTON, Calif.--(BUSINESS WIRE)--November 17, 2025--TearOptix, Inc., a pioneering contact lens ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio I’ve said it before: There are four ...

Please provide your email address to receive an email when new articles are posted on . Noninvasive or minimally invasive approaches may be the solution for presbyopia before the onset of age-related ...

Vuity contracts the iris sphincter muscle, constricting the pupil to improve near and intermediate visual acuity. The Food and Drug Administration (FDA) has approved the supplemental New Drug ...

The MarketWatch News Department was not involved in the creation of this content. The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by ...

Around age 40, patients often develop a fuzziness of vision close up, presbyopia–becoming farsighted and losing elasticity in their natural lenses. Docs prescribe reading glasses or bifocals, and the ...

Stay ahead with the most recent pipeline outlook for Presbyopia. Get insights into clinical trials, emerging therapies, and leading companies with Presbyopia @ Presbyopia Treatment Drugs The ...

DUBLIN--(BUSINESS WIRE)--The "Global Myopia and Presbyopia Treatment Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The market for myopia and presbyopia treatment is ...

HERZLIYA, Israel, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing an innovative pharmaceutical solution for the treatment ...

NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented ...

SHANGHAI, Sept. 2, 2021 /PRNewswire/ -- Arctic Vision, a China-based clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, today announced the clearance of the ...